Post Acute Medical sets the standards of future health care safety across industries
The COVID-19 pandemic led Post Acute Medical (PAM) to implement groundbreaking technology to combat the novel virus. By installing Integrated Viral Protection’s indoor biodefense system, PAM has been able to quell the spread of coronavirus infections in our facilities.
PAM strives to provide the best care to our patients and support recovery through education and research. By being first to market in embracing the IVP biodefense system, we’ve enhanced our commitment to delivering care in the safest environment possible.
Our top priority is the safety and well-being of our patients, staff and community. As we continue to monitor the spread of COVID-19, we’ve installed additional IVP biodefense system units in our acute care facilities network-wide. PAM’s Wilkes-Barre specialty facility continues to gain media coverage on the IVP biodefense system installed there.
Not only has the IVP biodefense system proven to eliminate the airborne transmission of COVID-19, but the system also effectively kills anthrax, influenza, rhinovirus and other biological species. PAM’s use of the IVP systems sets the precedent of a “new normal” for how hospitals, prisons, schools, offices and other commercial spaces address current and future airborne illnesses.
The pandemic has shown all industries the importance of embracing innovative technology and the need for public health mitigation techniques. PAM takes pride in leading medical and non-medical facilities in the right direction through unforeseen events by investing in innovative technology.
“The COVID-19 pandemic blindsided everyone, regardless of industry, but health care was hit especially hard,” said Anthony Misitano, President and CEO of Post Acute Medical. ”In the wake of such uncertainty of what was next and urgency to save lives and prevent the transmission of the novel virus, Post Acute Medical made the decision to install the IVP biodefense system in several of our specialty and rehabilitation hospitals to ensure we had an extra layer of protection from the virus. This decision is one which has proven advantageous at preventing the spread of COVID-19 and instilling our patients and employees with a renewed sense of confidence in their safety when they’re in our care.”
While all of PAM’s facilities continue to follow CDC guidelines to prevent the transmission of COVID-19, those that have installed the IVP biodefense system have an additional layer of protection from the virus. The system decreases virus transmissions and keep patients, employees and the community safe.